Exploring the dual role of SIVA1 in cancer biology

Natália Sudan Parducci1, Anali Del Milagro Bernabe Garnique1, Bruna Oliveira de Almeida1

  • 1Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.

Gene
|March 2, 2025
PubMed

Insights

The apoptosis regulator SIVA1 plays a dual role in cancer, promoting cell death in some contexts and tumor growth in others. Understanding SIVA1

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Homeostasis

Background:

  • Cancer remains a leading cause of global mortality, necessitating research into its complex molecular mechanisms.
  • The apoptosis regulatory protein SIVA1 is crucial for cellular homeostasis and has emerged as a significant factor in cancer development.
  • SIVA1's initial characterization as a pro-apoptotic protein interacting with CD27 has expanded to reveal diverse cellular roles.

Purpose of the Study:

  • To review the multifaceted roles of the apoptosis regulatory protein SIVA1 in cancer.
  • To explore SIVA1's molecular mechanisms, structural features, and cellular localization.
  • To discuss SIVA1's dual function in apoptosis induction and tumor promotion.

Main Methods:

  • Literature review of studies on SIVA1 function, interactions, and gene expression.
  • Analysis of SIVA1's structural characteristics, including its amphipathic helix and death domain homology region.
  • Examination of SIVA1's interactions with proteins like the BCL2 family and its localization in cytoplasm and nucleus.

Main Results:

  • SIVA1 exhibits pro-apoptotic activity by interacting with anti-apoptotic BCL2 family proteins.
  • SIVA1's expression is linked to tumor differentiation, with presence in both cytoplasm and nucleus.
  • SIVA1 demonstrates context-dependent tumor-promoting properties in certain cancer types.

Conclusions:

  • SIVA1 possesses a complex, dual role in cancer, acting as both an apoptosis inducer and a tumor promoter.
  • Further research into SIVA1's regulatory mechanisms is essential for developing targeted cancer therapies.
  • Clarifying SIVA1's specific roles in different cancer contexts is crucial for its clinical application.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.9K